Considering research waste in economic evaluations of low-dose computed tomography screening for lung cancer

Read full text Summarise with VIRAT
Authors: Jaime L. Peters, Tristan Snowsill, Sophie Robinson, Edward Griffin, Chris Hyde
Cited by: 0
References: 47

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

With the ongoing discussion around the implementation of low-dose computed tomography (LDCT) screening for lung cancer, increasing numbers of model-based economic evaluations have been conducted. We systematically reviewed the published literature for economic evaluations of LDCT screening for lung cancer in people at high risk, updating this review in 2024. We identified a total of 57 economic evaluations; two-thirds of which developed de novo decision-analytic models. In our most recent update, of the 22 economic evaluations identified, only one used a model published before 2021. There may be advantages to developing new models, but the huge possibility of research waste cannot be ignored. Better quality of reporting (both in terms of clarity and completeness), improving the availability of existing models, and comparative analysis of different models can help to advance modeling methods in areas of complexity, such as screening for cancer. Ultimately, this should lead to policy decisions based on the best available evidence.

Fields of Study & Subjects

Health Systems Economic Evaluations Quality of Life Lung Cancer Diagnosis and Treatment Healthcare cost quality practices

Publication details

Journal / source
International Journal of Technology Assessment in Health Care
Volume
42
Issue
1
Pages
e45–e45
Publication date
30 March 2026
Language
EN